StreetInsider.com
  • Log-In
  • |
  • Home
  • |
  • E-mail Alerts
  • |
  • My Headlines
  • |
  • Portfolio


  • Home
  • Menu
    • JOIN
    • SI Premium
    • Ratings
    • Mergers
    • Earnings
    • Dividends
    • IPOs
    • Hedge Funds
    • Premium Letters
    • Send a Tip
    • API/Data
  • JOIN
  • SI Premium
    • Full Feed View
    • Headline View
    • SI Premium Squawk Box
    • Alerts
    • Custom Headlines
    • Upgrade Your Current Account
    • API
  • Calendars
    • Co. NDR/Event Calendar
    • Dividend Calendar
    • Earnings Calendar
    • Event Driven
    • FDA Calendar
    • Investor Conferences
    • IPO Calendar
    • Merger Arb
    • Ratings Calendar
    • Stock Split Calendar
  • Ratings
    • Analyst Comments
    • Hot Analyst Comments
    • Analyst EPS Change
    • Analyst EPS View
    • Analyst PT Change
    • Credit Ratings
    • Downgrade News
    • Hot Downgrades
    • New Coverage News
    • Hot New Coverage
    • Upgrade News
    • Hot Upgrades
    • More...
  • Mergers
    • Merger News
    • Hot M&A News
    • Private Equity
    • Rumors
    • SPAC News
    • Spinoffs
    • Merger Arbitrage
    • Event Driven
    • 2021 Top M&A Deals
    • Top 50 Takeover Targets
    • More...
  • Earnings
    • Earnings Calendar
    • Earnings News
    • Hot Earnings
    • Guidance
    • Hot Guidance
    • Conference Calls
    • Earnings History Search
    • More...
  • Dividends
    • Dividend Calendar
    • Dividend News
    • Hot Dividends
    • Dividend Hike
    • Special Dividends
    • Stock Buybacks
    • Hot Stock Buybacks
    • Stock Splits
    • More...
  • IPOs
    • IPO News
    • Hot IPOs
    • Equity Offerings
    • Recent IPOs
    • Upcoming IPOs
    • 2021 Top IPOs
    • More...
  • Hedge Funds
    • 13D
    • 13F
    • 13G
    • Hedge Funds News
    • Hot Insider Trades
    • Insider Trades
    • More...
  • Premium Letters
    • Pulse Picks
    • Stealth Growth Insider
  • Send a Tip
  • API/Data
  • QUICK LINKS :
  • Goldman Sachs Conviction Buy List
  • Warren Buffett News
  • Elliott Management News
  • Follow @Street_Insider

Moderna (MRNA) remains comfortable with its guided range for FY23 Covid vaccine sales

Article Related Articles (2) Related SEC Filings (1) Stock Quotes (1)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/10/2026

1. META
2. SPY
3. USO
4. MU
5. MSFT
6. COST
7. IONS
8. CG
9. AVAV
10. SKHY

Top News Most Read Special Reports
  • Nasdaq ends sharply higher; chip surge offsets Iran worries
  • Software stocks slide as Starbucks builds AI tools to replace vendor software
  • Applied Materials surges as CEO signals multi-year chip boom
  • Oil prices settle 2% lower as economic worries outweigh supply risks
  • Meta falls as massive AI infrastructure spending plans overshadow chip progress
  • Key things to know ahead of SK Hynix’s blockbuster US listing
  • Meta falls as massive AI infrastructure spending plans overshadow chip progress
  • S&P Downgrades Oracle To 'bbb-/A-3'; Outlook Stable
  • Software stocks slide as Starbucks builds AI tools to replace vendor software
  • Citi names top picks in software ahead of Q2 earnings
  • After-Hours Stock Movers: LEVI, AZZ, AP
  • After-Hours Stock Movers: NKE, BE, STZ, RIG
  • After-Hours Stock Movers: AVAV, PRAX, VSH, CNXC, SHAZ
  • Comcast, Viridian Therapeutics jump premarket; Doximity slips
  • After-Hours Stock Movers: ON, SYNA, RKLB, DLHC
Go back to Moderna (MRNA) remains comfortable with its guided range for FY23 Covid vaccine sales

Form 8-K Moderna, Inc. For: Oct 16

October 16, 2023 8:59 AM EDT

... More


 
Free News Feed
Get our RSS Feed!
© Copyright 2026 StreetInsider.com
Home
Member's Home
Premium Content
Links
Entities
About StreetInsider
Get Our Content
Advertise with Us
Contact Us
Disclaimer
Privacy Policy
Do Not Sell My Information